Abstract
A new sulfonamide, sulfacytine (1-ethyl-N-sulfanilylcytosine) has a short half-life, is highly soluble throughout the usual urinary pH range, and urinary excretion is almost entirely as the free or microbiologically active form. Experimental mouse infections demonstrate a 2- to 3-fold bacteriostatic activity compared to sulfisoxazole. Plasma and urine concentrations following three dose schedules of sulfacytine (2 grams/day, 1 gram/day, 0·5 grams/day) were determined over a 7-day period by both colorimetric and microbiologic assay methods. These were compared to sulfonamide levels produced by the standard dose of sulfisoxazole (4 grams/day). Excellent agreement was found between the two methods, indicating that the colorimetric assay for free sulfacytine should accurately reflect microbiologic activity. Fifty per cent (50%) of the total daily dose given initially produces prompt levels so is the proper loading dose. By comparison to sulfisoxazole urine levels, 1 gram/day of sulfacytine appears to be the proper dose, produces urine concentrations at least 10 times the highest MIC found for sensitive microorganisms.
Get full access to this article
View all access options for this article.
